Circio invites to first half 2025 report and R&D update webcast on 28 August

Summary by AI BETAClose X

Circio Holding ASA (OSE: CRNA) will present its first-half 2025 financial results and a corporate update during a webcast on August 28th, 2025, at 10:00 CEST. The presentation will also include in vivo data showcasing enhancements to Circio's circVec AAV gene therapy technology, specifically focusing on generation 3's performance and future experimental plans. The company will provide an overview of ongoing testing and optimization of circVec generation 3, highlighting strong performance in new in vivo settings. The corporate update will cover unaudited first-half 2025 financial results and provide an update on financing and business development for the second half of 2025. The webcast can be accessed via Microsoft Teams (Meeting ID: 352 997 264 281, Passcode: dj23Wc6o) or by phone (+47 21402155, Phone conference ID: 591397143#). A recording will be available on Circio's webpage afterward.

Disclaimer*

UK 100

Latest directors dealings